Objective: The objective of this study was to determine risk factors for nosocomial infections (NIs) and predictors of mortality in patients with prosthetic vascular grafts (PVGs).
Prosthetic vascular grafts (PVGs) have been widely used for treating patients with peripheral arterial disease or limb ischemia. 1, 2 During the past several years, the growing prevalence of atherosclerosis and diabetes has resulted in increased use of PVGs. [1] [2] [3] A well-known complication of PVG surgery is graft infection. [4] [5] [6] [7] [8] [9] [10] In peripheral endovascular procedures, the incidence of PVG infection (PVGI) is minimal, ranging from <1% for abdominal aortic vascular grafts to >6% for infrainguinal vascular grafts. 4, [8] [9] [10] However, the incidence of other nosocomial infections (NIs), such as respiratory tract infections and urinary tract infections (UTIs), in patients undergoing PVG surgery remains unclear, 11 as has been determined in other groups of patients after surgery, such as patients undergoing general surgery, cardiac surgery, or lung surgery. [12] [13] [14] In addition, although few studies have reported risk factors for surgical site infection (SSI) after vascular surgery, no prospective studies have investigated other NIs. 15, 16 Factors influencing outcomes in patients with NIs after surgery are complex, involving not only the patient's personal condition but also intraoperative and postoperative events. Urgent operation, postoperative complications, age >70 years, and aortic PVGI have been identified as independent prognostic factors for in-hospital mortality in patients with PVGI. 3, 5, 10, [16] [17] [18] [19] However, there is limited information about the relationship between other NIs and outcome of patients who underwent PVG surgery. The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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In view of these findings, a prospective cohort study was designed to assess the incidence and risk factors of NIs as well as the outcome of patients who underwent abdominal aortic or peripheral PVG to determine predictors of in-hospital and long-term (36 months) mortality.
METHODS
Study population. A prospective cohort study was performed from April 2008 to August 2009 in the Hospital Universitario Marqués de Valdecilla, Santander, Spain, a tertiary university hospital with 900 beds. The study included patients who underwent PVG of the abdominal aorta with or without iliac-femoral involvement and peripheral PVG (infrainguinal arterial grafts). The followup period was 36 months. Patients younger than 15 years and those with severe immunodeficiency (eg, hematologic neoplasm, transplant, human immunodeficiency virus infection, congenital immunodeficiency) were excluded. Sample size was previously calculated; a total of 224 patients was estimated to allow the detection of a significant P value < .05 of a risk ratio (RR) of 3 with a statistical power of .8 for exposures, with a frequency of 10% in the nonexposed group. We anticipated a dropout rate of 10%.
For all study patients, the following characteristics were recorded at the time of admission or during hospitalization: age, sex, body mass index, smoking history, alcohol consumption, surgery in the previous year, active infections at the time of PVG surgery, and comorbidities. Comorbidities included the presence of chronic obstructive pulmonary disease, diabetes mellitus, renal failure (creatinine level $1.2 mg/dL), heart failure, acute stroke, ischemic cardiopathy, and arrhythmia due to atrial fibrillation. Data recorded for surgery included the following: emergency or regular surgery, administration of antibiotic prophylaxis (1 g of cefazolin 30 minutes before anesthesia and then every 8 hours until 24 hours after operation), preoperative American Society of Anesthesiologists risk score, surgeon who performed the operation, occurrence of surgical complications, blood transfusions, and requirement of hemodialysis or intraaortic balloon counterpulsation. Data recorded for the postoperative period included duration of intensive care unit stay, mechanical ventilation, nasogastric intubation, urinary tract catheter, and wound drain insertion.
Definitions. NIs were defined according to the Centers for Disease Control and Prevention criteria. 20 In the absence of a uniform criterion and an internationally accepted definition for a PVGI, we adapted the Centers for Disease Control and Prevention definitions of organspace SSIs corresponding to group 3 of the Szilagyi classification and the definitions by Legout et al and Erbs et al. 9, 10, [20] [21] [22] We considered a patient to have a PVGI if, at a minimum, one of the following criteria were met:
(1) the patient had an isolated microorganism that was aseptically obtained from a biopsy specimen or swab of the immediate area around the graft; (2) there was histopathologic or radiologic evidence of an infection involving the graft and the surrounding tissue; or (3) the patient had continuous bacteremia in the presence of a graft with no other apparent focus of infection. When potential contaminants such as coagulase-negative staphylococci or Propionibacterium acnes were present, the infection had to meet either criterion 1 or criterion 2.
Patients who developed NIs were receiving postoperative antibiotics according to the source of infection, the isolated microorganism, and the discretion of the treating physician, which followed international [23] [24] [25] and Spanish [26] [27] [28] treatment guidelines adapted to local data on antimicrobial susceptibility. In-hospital patient mortality was defined as any death, regardless of its cause, occurring during hospitalization in our center. Long-term mortality was defined as any death within a period of 36 months since hospital admission.
Postdischarge surveillance was conducted by reviewing all the emergency department forms, by outpatient interviews conducted by the surgeon in the surgery clinic, and by brief telephone interview of patients or their family members. The RR, adjusted odds ratio, and 95% confidence intervals (CIs) were calculated. All tests were two tailed, and P values of .05 were considered to be statistically significant. Statistical analyses were performed using R statistical software version 3.1.2 (R Foundation for Statistical Computing, Vienna, Austria).
Ethics. This study was approved by the Ethics Committee of the Autonomous Community of Cantabria, Spain. All patients signed informed consent to participate in the study. The study met the ethical principles stated in the Declaration of Helsinki and the international Good Clinical Practice guidelines.
RESULTS
Patient characteristics. During the study period, 261 patients underwent vascular graft surgery. The indication for vascular graft was aortic aneurysm in 49 (18.77%) patients (abdominal aortic PVG: aortobifemoral, 30; aortounifemoral, 7; tube graft, 6; and aortoiliac, 6) and a lower limb arteriopathy in 212 (81.23%) patients (peripheral PVG: above knee, 51; below knee, 161). Table I shows the main characteristics for all patients and for the subgroup of nosocomially infected patients and the comparison of patients with aortic abdominal PVG and peripheral PVG. Among the patients, 230 (88.12%) were male, with a mean age of 67.57 (standard deviation, 10.82) years (range, 38-90 years).
Seventy-one (27.02%) patients acquired an NI after surgery, 26.76% of whom had more than one episode of infection. Forty-two (16.09%) patients developed an SSI, 15 (5.75%) had a respiratory infection (5 pneumonias), 15 (5.75%) had a UTI (1 developed sepsis), 9 (3.45%) had bacteremia (3 catheter related), and 17 had other infections (Table I) . Of the 42 SSIs, 61.9% occurred in the lower extremities (14 superficial, 10 deep, and 2 PVGI) and 38.1% in the abdomen (7 superficial, 7 deep, and 2 PVGI). The two patients with abdominal aortic PVGI had aortobifemoral grafts, and the two with peripheral PVGI had femoropopliteal grafts. One patient with abdominal aortic PVGI and both patients with peripheral PVGI had a lower extremity skin and soft tissue infection (SSTI) at the original operation.
Patients with abdominal aortic PVG and with peripheral PVG had a similar rate of NIs and SSIs. However, patients with abdominal aortic PVG had a significantly higher rate of respiratory tract infections (P < .0001) and UTIs (P ¼ .010) and more infections per patient (P < .0001) than those with peripheral PVG (Table I) .
Overall, 68 (26.05%) patients had some type of noninfectious complications in the postoperative period: hemorrhage/hematoma in 12 (4.60%); cardiac, respiratory, or renal complications in 12 (4.60%); graft thrombosis in 7 (2.68%); postoperative ileus in 6 (2.30%); ischemic ulcers in lower extremities in 4 (1.53%); wound dehiscence in 3 (1.15%); anemia in 2 (0.77 %); and leg amputation in 2 (0.77%) patients. There were no significant differences in the number of noninfection complications between patients with abdominal aortic PVG and patients with peripheral PVG (P ¼ .129). In-hospital and long-term mortality rates were similar in both types of patients (P ¼ 1, P ¼ .138, respectively; Table I ). A total of 130 microorganisms were isolated from the wound exudate (59.2% gram-negative, 39.2% grampositive, and 1.5% Candida species). The primary bacterial species isolated were as follows: 18 Staphylococcus aureus (13 methicillin resistant), 18 Pseudomonas aeruginosa, 12 coagulase-negative staphylococci, 12 Escherichia coli, 11 Enterobacter cloacae, 9 Enterococcus faecalis, 8 Acinetobacter baumannii, 6 Serratia marcescens, and 2 Enterococcus faecium. From the urine cultures, 16 isolates were obtained: 4 E. coli, 4 P. aeruginosa, 2 E. cloacae, 2 Proteus mirabilis, 2 E. faecalis, 1 E. faecium, and 1 Candida albicans. Two microorganisms were isolated from the sputum: one Moraxella catarrhalis and one E. coli. From blood cultures, 13 microorganisms were isolated: 5 coagulase-negative staphylococci, 2 E. coli, 1 Acinetobacter, 1 Corynebacterium jeikeium, 1 P. aeruginosa, 1 methicillin-resistant S. aureus, 1 E. faecium, and 1 C. albicans.
Risk factors for NI. Table I shows the main characteristics of patients with NI. Multivariate logistic regression showed mechanical ventilation, active lower extremity SSTIs, and low hemoglobin levels on admission as significant predictors of NI (Table II) . When analyzed separately, in patients with abdominal aortic PVG, the significant predictors of NI were active lower extremity SSTI and mechanical ventilation (Table II) . There was a significant association between patients with respiratory infection and mechanical ventilation (P < .0001). Thus, 24.0% (six patients) of those who had mechanical ventilation became infected vs 4.1% (eight patients) without ventilation who became infected (RR, 5.83; 95% CI, 2.20-15.40). In patients with peripheral PVG, the significant predictors of NI were also active lower extremity SSTI, low hemoglobin levels on admission, and emergency surgery (Table II) . In addition, UTIs were more frequent in patients with peripheral PVG; nevertheless, these infections were not associated with the presence or duration of the urinary catheter (RR, 1.62; 95% CI, 0.93-2.83; P ¼ .134).
The interventions were performed by eight surgeons, and there was no relationship between any specific surgeon and NI or mortality. 
OUTCOME
In-hospital mortality. All-cause in-hospital mortality was observed in five (1.92%) patients, four of whom died of infection. All in-hospital deaths occurred within the first month after surgery. Survival probability was 0.96 at 1 month after surgery. Variables associated with in-hospital mortality were active lower extremity SSTIs, presence of noninfectious surgical complications (5 massive bleeding, 2 retroperitoneal hematomas, 1 acute pulmonary edema, 1 anaphylactic shock, 1 cardiogenic shock, 1 hemodynamic angina, 1 arrhythmia), and tracheostomy requirement. There were also significant differences in age and postsurgical glucose levels that increased the risk by 2% for each 1 mg/dL (Table III) . A Cox multivariate model adjusted by age, gender, surgical complications, active lower extremity SSTIs, and glucose levels showed significant differences in survival times, depending on the presence of surgical noninfectious complications, active lower extremity SSTIs, and high blood glucose levels (Table III) . Comparison of survival curves showed differences in cases of postsurgical noninfectious complications: the survival probability at 1 month was 0.43 vs 0.96 for patients with and without complications, respectively; and for tracheostomy, the survival probability was 0.50 at half a month vs 0.96 at 1 month for patients with and without it, respectively.
Long-term mortality. All-cause mortality at 3 years since hospital admission was observed in 31 patients (11.88%), 1 related to infection 167 days after operation. Regarding the patients with PVGI, one patient with abdominal aortic PVGI died at home 75 days after surgery because of a cerebrovascular accident, and the other one and the two patients with peripheral PVGI were alive at the last follow-up. The probability of survival at 12, 24, and 36 months was 0.94, 0.92, and 0.87, respectively (Fig 1) .
Comparison of Kaplan-Meier curves did not show shorter survival times for NI, American Society of Anesthesiologists class, and ischemic cardiopathy. However, it did show differences in kidney failure (P ¼ .009), cardiac arrhythmia due to ventricular fibrillation (P ¼ .0008), heart failure (P ¼ .02), active limb SSTIs (P ¼ .02), and SSI (P ¼ .03; Fig 2) .
In bivariate analyses, a significant increase in risk of long-term mortality was observed with age and the presence of chronic diseases at the time of the bypass operation, such as kidney failure, cardiac arrhythmia due to ventricular fibrillation, ischemic cardiopathy, and heart failure. In addition, certain analytical levels related to the presence of these chronic diseases, such as an increase in creatinine levels on admission and at discharge or a decrease of hemoglobin levels on admission, statistically decreased survival. Active lower extremity SSTIs at admission, SSI, and presence of noninfectious complications after surgery were also identified as prognostic factors (Table III) . The type of bypass was not associated with an increased mortality (RR for peripheral PVGI, 2.32; 95% CI, 0.70-7.64; P ¼ .17).
Cox multivariate analysis adjusted by age, gender, kidney failure, cardiac arrhythmia due to ventricular fibrillation, heart failure, active limb SSTIs, serum creatinine levels on admission and at discharge, hemoglobin levels on admission, and SSI showed significance for age, creatinine levels on discharge, hemoglobin levels on admission, and SSI. The presence of noninfectious complications after bypass operation also increased the risk of death by almost three times but was not statistically significant (P ¼ .054; Table III) .
DISCUSSION
This study prospectively evaluated the risk factors and outcome of 261 consecutive patients who underwent abdominal aortic or peripheral PVG surgery during 1 year at a university teaching hospital and were Multivariate Cox regression: adjusted by age, sex, renal failure, arrhythmia due to atrial fibrillation, heart failure, active lower extremity SSTIs, serum creatinine levels on admission and at discharge, hemoglobin levels on admission, and SSI. prospectively observed for a long time (36 months). In this study, we attempted to clarify the impact of the patient's comorbidities and perisurgical aspects on the development of primary NIs in patients with PVG surgery by identifying those factors that are independent predictors for infection and mortality. A majority of the patients were men, with a mean age >65 years. More than 80% of the patients needed a vascular graft because of arterial disease of the lower extremities and were current or former smokers. Hypertension, diabetes, hypercholesterolemia, chronic obstructive pulmonary disease, and ischemic cardiopathy were the primary comorbidities. However, when patients with aortic abdominal or peripheral PVG were separately considered, the peripheral PVG group was older and had more patients with diabetes, heart failure, and previous surgery than the aortic abdominal PVG group. Similar characteristics were described in other series of PVG surgery. [4] [5] [6] [7] Twenty-seven percent of all patients acquire an NI after surgery, with 26.8% of them having more than one episode of infection. Patients with aortic abdominal PVG have a greater number of NIs per patient. However, the NI rate was similar in patients who underwent aortic abdominal or peripheral PVG. The principal NI was SSI (primarily in the lower extremities and in patients with peripheral PVG), followed by a respiratory infection (more frequent in patients who underwent aortic abdominal PVG and associated with mechanical ventilation and longer intensive care unit stay), UTI, and bacteremia. UTIs were more frequent in patients with peripheral PVG; nevertheless, they were not associated with the presence or duration of the urinary catheter. This finding supports that the UTI source may be related to contamination of the wound or skin area.
Only four (1.5%) patients developed a PVGI (two with aortic abdominal graft and two with peripheral bypass). This low rate of graft infections, which is similar to other vascular graft series, [4] [5] [6] [7] [8] [9] [10] contrasts with the high numbers of other NIs, especially with deep or superficial SSI. Several studies have reported incidences of SSI after vascular operation between 5% and 10%, mainly in patients with infrainguinal bypass. 16, 29 A recent meta-analysis of 38 published articles of the outcomes after femoropopliteal bypass found a mean SSI rate of 7.8%. 30 In our work, these numbers can be explained by the different methodology used because our study included all consecutive patients and involved an active detection of all NIs, especially SSI, including superficial SSI. In addition, possibly patients with a worse clinical condition and more complicated vascular disease are referred to our tertiary teaching hospital. Therefore, we propose an active detection of the primary NIs to prevent them. It is noteworthy that 16% of patients had an active lower extremity SSTI at the time of surgery, such as infection of an ischemic ulcer or cellulitis, in the same or different area where the PVG was placed. These infections do not contraindicate surgery; however, they have emerged as a key predictor factor of NI in abdominal aortic and peripheral PVG, primarily for UTI. This finding could be explained by the possibility of bacterial spread either at the time of operation or later to the surgical area, as suggested by other authors. 29, 30 These findings suggest that if the bypass placement is not urgent, surgery should be delayed until the infection is resolved. Although several studies showed the risk factors for development of an SSI in patients undergoing PVG, there are no studies analyzing the factors that increase the risk of other types of NIs, as found for other operations. [11] [12] [13] [14] [15] 31 Independent risk factors for NI for all the patients were active lower extremity SSTIs, low hemoglobin levels on admission, and the need for mechanical ventilation.
Active lower extremity SSTI was also a separate independent risk factor for IN in both types of PVG. In addition, in abdominal aortic PVG, mechanical ventilation was the primary risk factor, whereas in peripheral PVG, it was undergoing an emergency operation.
In our cohort, all-cause in-hospital mortality was 1.9% and all-cause mortality at 3 years was 11.9%, without differences between patients with aortic abdominal PVG and patients with peripheral PVG. This mortality is lower than that of Feinglas et al, 18 who reported a 30-day mortality of 4.8% in their study of 28,128 patients who underwent peripheral bypass. This discrepancy with our study could be due to different surgical strategies or that the data presented here are based solely on hospital deaths. Feinglas et al 18 also showed that 31.4% of patients were alive 5 years after their initial PVG without major amputation or subsequent bypass or revision procedures. However, no factors associated with mortality were described. Our results from this study confirm that chronologic age, an active lower extremity SSTI at the time of surgery, and noninfectious complications are some critical determinants of in-hospital and long-term mortality. Postoperative high glucose level was also an independent prognostic factor for in-hospital mortality, as described previously. 2, 32 In contrast to other studies, 2,9 in our series, the type of bypass (aortic or peripheral) was not associated with a significant increase in mortality. Knowing the factors that affect mortality may favor the improvement of outcome of patients who undergo PVG surgery. Long-term mortality was affected primarily by the SSIs. Our findings show that the superficial SSI also influences the prognosis of these patients and that active surveillance of all hospital-acquired infections is highly desirable. An active lower extremity SSTI at the time of surgery was also associated with long-term mortality. Probably any SSI can be triggered by bacterial colonization of the wound during surgery, especially from the patient's skin or adjacent bowel, as has been shown for PVGI. 3 Moreover, long-term mortality was affected negatively by heart and kidney comorbidities. Kidney function has been shown to be an important predictor of survival, corroborated by the fact that high creatinine levels were also an independent risk factor of mortality. This study had several limitations. Potential bias might result from various surgical approaches. Moreover, although it is a prospective survey with a good number of recruited patients, the number of patients and deaths could be considered relatively small. There are, however, no other studies that include all patients consecutively and analyze the risk factors associated with a global NI, not PVGI alone, and with such a long-term follow-up.
CONCLUSIONS
Our findings indicate that the risk of NI depends on the need for mechanical ventilation for abdominal aortic PVG and low hemoglobin levels at admission and emergency surgery for peripheral PVG, whereas the presence of community-acquired lower extremity SSTIs at the time of surgery increases the risk of NI in both aortic abdominal PVG and peripheral PVG. These findings suggest that in those cases in which surgery is reasonably delayed, as for many abdominal or peripheral aneurysms, prior treatment of these infections would decrease the NI rate.
Mortality is determined by age, noninfectious complications, and the occurrence of SSI. Other factors related to the patient's intrinsic condition, such as comorbidities, may also play a role in mortality. All this information can help to adjust the criteria for selection of patients in PVG surgery and to assist in proper decision-making, considering the patient's comorbidities and the risks of surgery. Furthermore, prospective studies such as this one could help monitor outcomes in PVG surgery patients with an NI and possibly develop new surveillance protocols in patients at high risk. Infections after placement of a prosthetic graft, for either aortic or peripheral arterial reconstruction, are feared and potentially devastating complications. These infections can have significant morbidity and can also lead to subsequent infections. In this issue of the Journal of Vascular Surgery, Fariñas et al report their experience with postoperative infectious complications after placement of prosthetic grafts for both lower extremity and aortic reconstruction. Their all-cause infection rate was 27.2%. The majority of infections were surgical site infections, and only two graft infections were noted. The authors identified preoperative active lower extremity soft tissue infection as an independent risk factor for infectious complications after both aortic and lower extremity operations. Although active lower extremity infection may not be able to be resolved for patients with advanced critical limb ischemia or those who undergo emergent aortic surgery, efforts should be undertaken to treat soft tissue infection before elective aortic aneurysm repair. Prolonged mechanical ventilation was noted to be a predictor for infectious complications after aortic surgery, once again emphasizing the importance of expeditious extubation in the immediate postoperative period, although it is unclear whether this is a marker of overall illness.
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There are several lessons to be learned from this analysis. Studies of postoperative infectious complications should not combine very different procedures together as "vascular surgery procedures." To correctly identify high-risk patients and to set in place systems for improvement, each specific type of intervention and indication needs to be closely examined. Leg bypass and aortic surgery are very different from one another with regard to a number of issues. For example, postoperative nasogastric tubes are often used after aortic procedures and seldom after leg bypass. Prolonged intubation with postoperative tracheostomy placement is less of an issue for lower extremity bypass as it is for major open abdominal surgery. Finally, for aortic surgery, an operation performed for aneurysmal disease is very different from one executed to treat occlusive disease, and a ruptured aneurysm is much different from an elective aneurysm repair. To decrease these rates of postoperative infections, risks identification and interventions should be tailored for specific scenarios.
Studies need to be optimally designed to answer the questions that they set up to ask. Future prospective work is needed as granular details are needed, including surgical and preparation technique. Risks factors identified in this study, such as poor glucose control, anemia, and prolonged ventilation, can also be analyzed and teased out to see if they are really factors that predict a poor outcome or merely markers for ill and sick patients with more advanced disease. As such, risk reduction methods should focus specifically on each procedure and indication.
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